ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for SPYRE THERAPEUTICS, INC. · Biotechnology company focused on treatments for gastrointestinal and rheumatic diseases.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $40,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Issues related to monoclonal antibody products.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.